Get access

A treatable new cause of chorea: Beta-ketothiolase deficiency

Authors

  • Daniela Buhaş MD,

    1. Department of Medical Genetics, Montreal Children's Hospital, Montréal, Quebéc, Canada
    2. McGill University Health Centre, Montreal Children's Hospital, Montréal, Québec, Canada
    Search for more papers by this author
  • Geneviève Bernard MD,

    1. Department of Neurology and Neurosurgery, Montreal Children's Hospital, Montréal, Québec, Canada
    2. McGill University Health Centre, Montreal Children's Hospital, Montréal, Québec, Canada
    Search for more papers by this author
  • Toshiyuki Fukao MD, PhD,

    1. Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, Japan
    Search for more papers by this author
  • Jean-Claude Décarie MD,

    1. Department of Medical Imaging, CHUM, Université de Montréal, Montréal, Québec, Canada
    2. Division of Medical Genetics, Department of Pediatrics, Université de Montréal, Montréal, Québec, Canada
    Search for more papers by this author
  • Sylvain Chouinard MD,

    1. CHU Sainte-Justine, Université de Montréal, Montréal, Québec, Canada
    Search for more papers by this author
  • Grant A. Mitchell MD

    Corresponding author
    1. André Barbeau Movement Disorders Unit, CHUM, Université de Montréal, Montréal, Québec, Canada
    2. Division of Medical Genetics, Department of Pediatrics, Université de Montréal, Montréal, Québec, Canada
    Search for more papers by this author

  • Relevant conflicts of interest/financial disclosures: Sylvain Chouinard has consulted and served on the advisory board of Teva, AbbVie, Novartis, UBC and Allergan and has received honoraria from Teva, AbbVie, Novartis and UBC. Geneviéve Bernard has served as a consultant for Actelion Pharmaceuticals.

  • Full author roles may be found in the Acknowledments section online.

Ancillary